Covering SB without PCI SB (group A) | N | Covering SB + PCI SB (group B) | N | Difference | CI; P | |
---|---|---|---|---|---|---|
Thrombectomy before PCI (no, percent) | 6 (9.4%) | 64 | 4 (11.8%) | 34 | 1.29a | (0.34; 4.92) 0.71 |
Primary stenting (no, percent) | 19 (29.7%) | 64 | 8 (23.5%) | 34 | 0.73a | (0.28; 1.90) 0.52 |
Stent diameter (mm, mean, range, SD) | 2.7 (2.0 – 3.5, 0.31) | 64 | 2.8 (2.0 – 3.5, 0.38) | 34 | −0.15b | (−0.29; -0.01) 0.04 |
Stent length (mm, mean, range, SD) | 17.6 (8.0 – 58.0, 8.8) | 64 | 20.7 (8.0 – 44.0, 8.8) | 34 | −0.18c | (−0.36; -0.00) 0.05 |
Drug eluting stent (no., percent) | 36 (56.3%) | 64 | 17 (50.0%) | 34 | 0.78a | (0.34; 1.79) 0.56 |
Glycoprotein IIB/IIIA antagonists (no., percent) | 9 ( 14.1%) | 64 | 8 (24.2%) | 34 | 1.88a | (0.65; 5.43) 0.24 |
Duration of x-ray, min (mean, range, SD) | 18.1 (2.7-220; 28.5 ) | 64 | 20.1 (5.8-51.4; 12.2 ) | 34 | −0.36c | (−0.67; -0.06) 0.02 |
Amount of contrast medium, ml (mean, range, SD) | 225.8 (70–640; 104.0) | 64 | 307.4 (180–470; 83.9 ) | 34 | −81.5a | (−122.8; -40.3) <0.001 |